Mobia Medical, Inc.

Three months to Jun 30, 2026, against the same quarter a year earlier.

• Revenue$13.5mRevenue, Q2 FY2026, three months to 2026-06-30$13.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001193125-26-344893.Report this figure+102.4% on a year earlier
• Gross margin83.2%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $11.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-11, accession 0001193125-26-344893.Revenue: $13.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001193125-26-344893.Report this figure+1.0 pts on a year earlier
• Operating margin−132.7%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$17.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344893.Revenue: $13.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001193125-26-344893.Report this figure+24.0 pts on a year earlier
• Net margin−155.8%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$21.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344893.Revenue: $13.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-11, accession 0001193125-26-344893.Report this figure+1.4 pts on a year earlier
• Diluted EPS−$1.10Diluted EPS, Q2 FY2026, three months to 2026-06-30−$1.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001193125-26-344893.Report this figure+91.2% on a year earlier
• Free cash flow−$17.2mdFree cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$15.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001193125-26-344893. Derived: 6-month figure less the 3-month figure.Capital expenditure: $1.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001193125-26-344893. Derived: 6-month figure less the 3-month figure.Report this figure−56.5% on a year earlier

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.